Free Trial

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 7 of 15

 
 

GSK (NYSE:GSK)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
5 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$50.00 (31.5% Upside)

About GSK

GSK logoGSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
8/27/2024BarclaysUpgradeHold
8/7/2024ArgusUpgradeStrong-Buy
7/8/2024UBS GroupDowngradeBuy ➝ Neutral
7/2/2024Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$52.50 ➝ $53.00
6/24/2024CitigroupUpgradeStrong-Buy
6/20/2024Berenberg BankUpgradeStrong-Buy
5/30/2024The Goldman Sachs GroupInitiated CoverageNeutral$47.00
3/4/2024GuggenheimUpgradeNeutral ➝ Buy
2/13/2024CitigroupUpgradeNeutral ➝ Buy
1/23/2024Morgan StanleyInitiated CoverageEqual Weight
 

[SHOCKING] Crypto Document Leak… (Ad)

The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes.

Download your digital copy now